Immune alterations and immunotherapy prospects in head and neck cancer

By Varilla Vincent  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1241-1256

Informa Healthcare

Access to resources Recommend Favorite

STAT3 as a therapeutic target in head and neck cancer

By Leeman Rebecca J   Lui Vivian Wai Yan   Grandis Jennifer Rubin  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite

Selenium and immunocompetence in patients with head and neck cancer

By Kiremidjian-Schumacher L.   Roy M.   Glickman R.   Schneider K.   Rothstein S.   Cooper J.   Hochster H.   Kim M.   Newman R.  

Biological Trace Element Research, Vol. 73, Iss. 2, 2000-02 ,pp. : 97-111

Humana Press, Inc

Access to resources Recommend Favorite

Genetic variations and head and neck cancer risks

By Masood Nosheen   Yasmin Azra   Kayani Mahmood  

Molecular Biology Reports, Vol. 41, Iss. 4, 2014-04 ,pp. : 2667-2670

Springer Publishing Company

Access to resources Recommend Favorite

Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells

By Wisniewska-Jarosinska Maria   Sliwinski Tomasz   Kasznicki Jacek   Kaczmarczyk Dariusz   Krupa Renata   Bloch Karolina   Drzewoski Jozef   Chojnacki Jan   Blasiak Janusz   Morawiec-Sztandera Alina  

Molecular Biology Reports, Vol. 38, Iss. 6, 2011-08 ,pp. : 3679-3688

Springer Publishing Company

Access to resources Recommend Favorite